| New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals. | |
| | |
MedLine Citation:
|
PMID: 19770495 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Juvenile idiopathic arthritis (JIA) is the most common paediatric rheumatic disease with significant long-term morbidity and mortality. Major advances have taken place in recent years in our understanding and the evidence base of JIA. The advent of biological therapies has opened a major new era in the medical management of JIA with recent trials published of etanercept, infliximab, adalimumab, abatacept, tocilizumab and anakinra. National and international collaborative clinical and research networks are ideally placed to enable future advances in the management of JIA and all paediatric rheumatic disorders. This review follows on from Part 1 of a review of recent advances in non-biological therapies in JIA, and focuses on the significant new advances in biological therapies in managing JIA. |
| | |
Authors:
|
M W Beresford; E M Baildam |
Related Documents
:
|
10219915 - Recent advances in the pathophysiology and management of preterm premature rupture of t... 10246185 - Deficiencies in efficiency. 9805285 - Pharmacological treatment of paraphilias with a focus on antidepressants. 9709645 - Soft tissue management with metal-ceramic and all-ceramic restorations. 15038865 - A multi-district audit of the management of syphilis in genitourinary medicine clinics ... 18087645 - Rehabilitation of erectile function following radical prostatectomy. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Archives of disease in childhood. Education and practice edition Volume: 94 ISSN: 1743-0593 ISO Abbreviation: Arch Dis Child Educ Pract Ed Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-09-22 Completed Date: 2009-12-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101220684 Medline TA: Arch Dis Child Educ Pract Ed Country: England |
Other Details:
|
Languages: eng Pagination: 151-6 Citation Subset: IM |
Affiliation:
|
Institute of Child Health, Alder Hey Children's NHS Foundation Trust, University of Liverpool, Liverpool, UK. m.w.beresford@liverpool.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
therapeutic use* Antirheumatic Agents / therapeutic use* Arthritis, Juvenile Rheumatoid / drug therapy* Biological Therapy* Child Humans |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antirheumatic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New advances in the management of juvenile idiopathic arthritis--1: Non-biological therapy.
Next Document: Minding the gap: training in adolescent medicine when formal training programmes are not available.